Smith-Lemli-Opitz Syndrome

What is Smith-Lemli-Opitz syndrome (SLOS)?

SLOS Chromosome SLOS is a metabolic disorder caused by a mutation in the DHCR7 (7-dehydrocholesterol reductase) gene on chromosome 11. This gene codes for an enzyme that is involved in the production of cholesterol. People who have SLOS are unable to make enough cholesterol to support normal growth and development.

Cholesterol is an essential component of the cell membrane and tissues of the brain. A person who can't make enough cholesterol will therefore experience poor growth, developmental delays, and mental retardation. People with this disorder may also have a range of physical malformations (such as extra fingers or toes) and problems with internal organs (such as the heart or kidney).


How do people get SLOS?

SLOS is inherited in an autosomal recessive pattern. Because it is recessive, a child will not have the symptoms of the disorder unless both parents pass on a defective copy of the DHCR7 gene. This can only happen if both parents are carriers. A carrier is a person who has one good copy and one mutated copy of the DHCR7 gene, but does not experience any symptoms of the disorder. If both parents are carriers, each of their children will have a 25 percent chance of inheriting the disorder.


What are the symptoms of SLOS?

Symptoms vary from person to person, depending upon the amount of cholesterol they can produce. In addition to mental retardation and poor growth, common physical signs of SLOS are a cleft palate (a split upper lip), malformed genitals (in males), and polydactyly (extra fingers or toes).

Other symptoms that may be present at birth include: microcephaly (small head), webbing between the second and third toes, drooping eyelids, heart defects, hearing or sight loss, and difficulties feeding.

With the right medical care and proper diet a person with SLOS can experience a normal life expectancy, although independent living is unlikely due to mental retardation. Sadly, children with the most severe cases of SLOS (produce almost no cholesterol) usually die a few months after birth.


How do doctors diagnose SLOS?

An ultrasound (a machine that uses sound waves to look inside a mother's uterus) can reveal the hallmark physical deformities before a baby is born. Amniocentesis and chorionic villus sampling (CVS) can also determine whether the baby will be born with SLOS.

After birth, a blood test can determine whether someone has the disorder. The test looks for low levels of cholesterol, as well as higher-than-normal levels of a precursor of cholesterol.

How is SLOS treated?

There is no real treatment for SLOS, but cholesterol supplements can improve children's growth and development. Surgery may be necessary to correct some of the physical deformities (cleft palate, heart defects) associated with the disorder.

Choleserol

Interesting facts about SLOS

In the United States, about 1 out of every 20,000 babies is born with SLOS.

SLOS was initially named RSH, for the initials of the first three patients diagnosed with the disorder. It was later changed to honor the three geneticists (David Smith, Luc Lemli, and John Opitz) who first described the disorder in 1964.

Where can I go for more information on SLOS?

Autosomal Recessive

+1.801.585.3470

383 Colorow Dr, Salt Lake City, Utah 84108

APA format:
Genetic Science Learning Center (2014, June 22) Smith-Lemli-Opitz Syndrome. Learn.Genetics. Retrieved July 29, 2014, from http://learn.genetics.utah.edu/content/disorders/singlegene/slos/
MLA format:
Genetic Science Learning Center. "Smith-Lemli-Opitz Syndrome." Learn.Genetics 29 July 2014 <http://learn.genetics.utah.edu/content/disorders/singlegene/slos/>
Chicago format:
Genetic Science Learning Center, "Smith-Lemli-Opitz Syndrome," Learn.Genetics, 22 June 2014, <http://learn.genetics.utah.edu/content/disorders/singlegene/slos/> (29 July 2014)